Please try another search
Breaking News
For the fiscal year ended 31 December 2015, BG Medicine, Inc. revenues decreased 44% to $1.6M. Net loss applicable to common stockholders decreased 14% to $7M. Revenues reflect Product revenues decrease of 50% to $1.4M. Lower net loss reflects Selling and marketing decrease of 87% to $302K (expense), General and administrative decrease of 20% to $3.6M (expense), Research and Development decrease of 26% to $1.8M (expense).
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Total Revenue | 0.29 | 0.33 | 0.51 | 0.44 |
Gross Profit | 0.21 | 0.23 | 0.33 | 0.29 |
Operating Income | -0.9 | -1.03 | -1.45 | -1.26 |
Net Income | -0.9 | -1.02 | -2.03 | -1.35 |
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Total Assets | 2.13 | 3.36 | 1.37 | 2.59 |
Total Liabilities | 1.51 | 2.04 | 3.74 | 3.16 |
Total Equity | 0.62 | 1.32 | -2.38 | -0.57 |
Period Ending: | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -3.67 | -2.55 | -2.22 | -1.39 |
Cash From Investing Activities | 0.01 | 0.01 | 0.01 | |
Cash From Financing Activities | 1.06 | 1.06 | -1.74 | -1.12 |
Net Change in Cash | -2.6 | -1.48 | -3.94 | -2.51 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review